Paramesu Biotech Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 26.26 Cr
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 239.38 Cr
- Satisfied Charges ₹ 40.00 Cr
About Paramesu Biotech
Paramesu Biotech Limited (PBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 07 September 2011 and has a history of 13 years and four months. Its registered office is in Devarapalli, Andhra Pradesh, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 26.26 Cr.
The company currently has active open charges totaling ₹239.38 Cr. The company has closed loans amounting to ₹40.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Paramesu Biotech Limited India is Sanyukta Jodhani as COMPANY SECRETARY.
Company Details
-
Location
Devarapalli, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232AP2011PLC076378
-
Company No.
076378
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
07 Sep 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
What products or services does Paramesu Biotech Limited offer?
Paramesu Biotech Limited offers a wide range of products and services, including Yarns & Threads, Threads, Flavours & Aromatics, Starch Powder, Pharmaceutical Medicine.
Who are the key members and board of directors at Paramesu Biotech?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanyukta Jodhani | Company Secretary | 01-Aug-2022 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Krishna Tetali | Director | 07-Sep-2011 | Current |
Upendra Tetali | Director | 07-Sep-2011 | Current |
Ananda Adavani | Director | 07-Sep-2011 | Current |
Satish Tetali | Director | 07-Sep-2011 | Current |
Financial Performance of Paramesu Biotech.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Paramesu Biotech?
Unlock access to Paramesu Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹239.38 Cr
₹40.00 Cr
Charges Breakdown by Lending Institutions
- Indian Bank : 239.38 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
30 Sep 2022 | Indian Bank | ₹84.38 Cr | Open |
11 Mar 2019 | Indian Bank | ₹35.00 Cr | Open |
03 Aug 2013 | Indian Bank | ₹120.00 Cr | Open |
23 Jan 2023 | Hdfc Bank Limited | ₹35.00 Cr | Satisfied |
15 Jun 2020 | Indian Bank | ₹5.00 Cr | Satisfied |
How Many Employees Work at Paramesu Biotech?
Unlock and access historical data on people associated with Paramesu Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paramesu Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paramesu Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.